• World of DaaS
  • Posts
  • Ensuring sensitive data is compliant is the realm of slow moving consultants

Ensuring sensitive data is compliant is the realm of slow moving consultants

Integral thinks we can move faster.

As data privacy concerns dominate public discourse, one startup is tackling the complex world of regulated data head-on. Integral, co-founded by CEO Shubh Sinha, is pioneering a new approach to data compliance that is accelerating how industries handle sensitive information.

In the current landscape, the process of ensuring data compliance is painfully inefficient. Large companies, particularly in healthcare, rely heavily on consultants and manual processes to navigate the complex web of regulations. This approach is not only time-consuming but also prone to errors and overly conservative decisions.

"Typically what happens is you have to bring in consultants and bring in their manager and bring in all the different data vendors to ensure that the dataset that's going to be sent to a client is compliant to do so," Sinha explains.

The result is a process that can take 10 to 12 weeks, significantly delaying critical business operations and potentially compromising data fidelity. As Sinha notes, "You have this storm of big delays and then bad data sets all resulting in a hundred million dollars ad budgets getting wasted". This inefficiency not only impacts business operations but can also delay crucial healthcare initiatives, potentially affecting patient outcomes.

Healthcare generates a staggering 30% of all data created globally, facing unique challenges when it comes to data distribution. The average healthcare journey involves over 40 touchpoints, creating a complex web of information that companies must navigate carefully.

"Healthcare represented the perfect beachhead for us because it's plagued with data fragmentation," Sinha explains. "The regulatory framework is, I would say, ahead in terms of there's just always been this compliance spotlight in healthcare."

For pharmaceutical giants like Pfizer, accessing and utilizing this data is crucial for everything from drug development to marketing campaigns. However, the process is far from straightforward. Before any data can be used, it must undergo rigorous compliance checks to ensure it meets regulatory standards such as HIPAA.

Integral's Game-Changing Approach: Automating Compliance

Integral's solution streamlines this process dramatically this process dramatically. By automating compliance checks and documentation generation, the company is reducing the time it takes to prepare data for use from weeks to potentially hours.

"What we do very, very over simplistically is we enable quick compliant data connectivity across all sensitive regulated data sets," Sinha states. This approach not only speeds up the process but also maintains data quality, striking a delicate balance between regulatory compliance and business needs.

The platform's ability to learn and adapt is particularly impressive. Sinha notes, "We have experts who help contribute to writing the policy associated with the company. That being said, we only bring in manual efforts when there's more bespoke edge cases, or maybe I should say custom use cases. I would say for most of our customers, 95% of it's automated because we've seen so much of it already."

This level of automation is a game-changer for industries dealing with sensitive data. It not only reduces the risk of human error but also allows companies to iterate and adapt their data strategies more quickly, potentially leading to faster drug development and more targeted healthcare interventions.

The Future of Regulated Data Management: Beyond Healthcare

While Integral has found its initial success in healthcare, Sinha's vision extends far beyond this single industry. The company is already eyeing expansion into other sectors where data privacy and compliance are critical concerns.

"Our plans for growth is to take what we've done with healthcare and HIPAA and expand that to where HIPAA, CCPA, Vermont state data privacy law, say Florida comes out with a law next year, those are configurations into our software," Sinha explains.

This approach positions Integral to become a crucial player in the evolving landscape of data privacy regulations. As more states and countries implement their own data protection laws, companies will need robust, flexible solutions to ensure compliance across multiple jurisdictions.

Sinha sees potential applications in retail, media, and other industries where large enterprises are increasingly relying on consumer data while navigating complex regulatory environments. "We're moving past our beachhead, but in many ways we did the hard thing to set us up for doing other things that are not as hard," he notes.

The implications of Integral's technology extend beyond mere compliance. By breaking down data silos and enabling more efficient use of information, the company could potentially impact everything from product development to pricing strategies. While Sinha is careful not to make sweeping claims about cost reductions, he does emphasize the potential for improved efficiency: "What I can guarantee today is that we reduce time to value for these consumers and patients."

As Integral continues to grow and expand its capabilities, it's clear that the company is at the forefront of a significant shift in how businesses handle sensitive data. By automating compliance and enabling more efficient data usage, Integral is not just solving a technical problem – it's potentially reshaping entire industries.

With data privacy concerns likely to intensify, solutions like Integral's may well become indispensable. As Sinha puts it, "Our goal is to make sure it's all an end-to-end very seamless process so that no inefficiencies can actually impact costs for people like you and me." It's a lofty goal, but one that could have far-reaching implications for businesses and consumers alike.

Reply

or to participate.